Try our Advanced Search for more refined results

3 Takeaways From DuPont's Proxy Battle Victory Over Trian

By Benjamin Horney (May 15, 2015, 5:27 PM EDT) -- DuPont Co. outlasted the only big-name activist investor that went the distance this proxy season, when all 12 of its director nominees were voted in by shareholders on Wednesday, and the monthslong battle between the chemical giant and billionaire activist Nelson Peltz and his Trian Fund Management LP taught companies and investors alike some valuable lessons....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!